COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,800 Articles (22,527 medRxiv, 8,273 bioRxiv)

Most recent first Previous |  Page 590: Articles 5891-5900  | Next

Trends in Low-Value Cancer Care During the COVID-19 Pandemic
Parikh, R. B., Civelek, Y., Ozluk, P., Drell, H. A., DeBono, D., Fisch, M. J., Sylwestrzak, G., Bekelman, J. E., Schwartz, A. L.
10.1101/2022.09.12.22279539 — Posted: 2022-09-14
Increasing Cases of SARS-CoV-2 Omicron Reinfection Reveals Ineffective Post-COVID-19 Immunity in Denmark and Conveys the Need for Continued Next-Generation Sequencing
Burkholz, S., Rubsamen, M., Blankenburg, L., Carback, R. T., Mochly-Rosen, D., Harris, P. E.
10.1101/2022.09.13.22279912 — Posted: 2022-09-14
SARS-CoV-2 containment was achievable during the early stage of the pandemic: a retrospective modelling study of the Xinfadi outbreak in Beijing
Wang, Y., Sun, K., Pan, Y., Yi, L., Huo, D., Wu, Y., Dong, S., Guo, J., Dou, X., Wang, W., Wu, S., Bai, X., Yu, H., Wang, Q.
10.1101/2022.09.12.22279850 — Posted: 2022-09-14
The epidemiology of long COVID in US adults two years after the start of the US SARS-CoV-2 pandemic
Robertson, M., Qasmieh, S., Kulkarni, S., Teasdale, C. A., Jones, H. E., McNairy, M., Borrell, L. N., Nash, D.
10.1101/2022.09.12.22279862 — Posted: 2022-09-14
Pregnant women's attitudes and behaviours towards antenatal vaccination against Influenza and COVID-19 in the Liverpool City Region, United Kingdom: cross-sectional survey
Kilada, S., French, N., Perkins, E., Hungerford, D.
10.1101/2022.09.13.22279846 — Posted: 2022-09-14
The SARS-CoV-2 spike N-terminal domain engages 9-O-acetylated α2-8-linked sialic acids
Tomris, I., Unione, L., Nguyen, L., Zaree, P., Bouwman, K. M., Liu, L., Li, Z., Fok, J. A., Rios Carrasco, M., van der Woude, R., Kimpel, A. L. M., Linthorst, M. W., Verpalen, E. C. J. M., Caniels, T. G., Sanders, R. W., Heesters, B. A., Pieters, R. J., Jimenez-Barbero, J., Klassen, J. S., Boons, G.-J., de Vries, R. P.
10.1101/2022.09.14.507904 — Posted: 2022-09-14
HLA variants and TCR diversity against SARS-CoV-2 in the pre-COVID-19 era
Buhler, S., Calderin, Z., Bettens, F., Schaefer, A., Dantin, C., Ansari, M., Mamez, A.-C., Masouridi-Levrat, S., Chalandon, Y., Ferrari-Lacraz, S., Villard, J.
10.1101/2022.09.14.507948 — Posted: 2022-09-14
Structure and Epitope of a Neutralizing Monoclonal Antibody that Targets the Stem Helix of β Coronaviruses
Deshpande, A., Schormann, N., Piepenbrink, M. S., Martinez-Sobrido, L., Kobie, J., Walter, M. R.
10.1101/2022.09.14.507947 — Posted: 2022-09-14
Validation and Establishment of a SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a pre-screening tool for the Plaque Reduction Neutralization Test
Merluza, J., Ung, J., Makowski, K., Robinson, A., Manguiat, K. J., Mueller, N., Audet, J., Chen, J. C.-y., Strong, J. E., Wood, H., Bello, A.
10.1101/2022.09.13.507876 — Posted: 2022-09-14
The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution
Moulana, A., Dupic, T., Phillips, A. M., Chang, J., Roffler, A. A., Greaney, A. J., Starr, T. N., Bloom, J. D., Desai, M. M.
10.1101/2022.09.13.507781 — Posted: 2022-09-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).